tirzepatide mounjaro for weight loss What's better loss, or Ozempic? New study provides answer Mounjaro (tirzepatide): Dual-Action Diabetes and

Semaglutide is a long-acting glucagon-like peptide 1 (GLP-1) agonist, while tirzepatide is both a GLP-1 agonist and a glucose dependent insulinotropic polypeptide (GIP)

Also find out about its general benefits, risks, and more.

Patients who reduced the frequency of GLP-1 dosing (from weekly to every other week) were able to maintain their weight loss and metabolic syndrome gains, as reported in this case series

The result is a sustained reduction in calorie intake and, over time, meaningful weight loss

Check our Semaglutide weight loss dosage chart to find the right dose for safe and effective weight management